| Application no. and date | 17175885.7 (espacenet) (Federated) (European Patent Register), 20130424 | | Patent/reg. no. and date | DK/EP 3444261, 20210113 | | Publication date | 20190220 | | Priority no. and date | US 201261687669 P, 20120427, US 201361775288 P, 20130308, US 201361780444 P, 20130313 | | EP pub. no. and date |
EP 3444261 20190220 | | Effective date | | | Applicant/owner | Reata Pharmaceuticals Holdings, LLC, 5320 Legacy Drive
Plano, TX 75024, US | | Applicant ref. no. | | | Inventor | ANDERSON, Eric, 602 Nicholas Ct.
Southlake, TX 76092, US,
LIU, Xiaofeng, 320 Meadowood Ln.
Coppell, TX 75019, US,
DECKER, Andrea, Spalenring 11
4055 Basel, CH | | Representative | | | Opponent | | | IPC Class | A61K 31/565 (2006.01) , A61P 29/00 (2006.01) , C07J 63/00 (2006.01) | | Title | 2,2-DIFLUORPROPIONAMIDDERIVAT AF BARDOXOLONMETHYL, FARMACEUTISKE SAMMENSÆTNINGER OG POLYMORFER DERAF TIL ANVENDELSE VED BEHANDLING AF VISSE LIDELSER | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
